ctrl K

Watchlist Price Alert

Kymera Therapeutics Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

29.98

-1.16 (-3.73%)

At close: May 14, 2025, 12:19 PM

Kymera Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	47.07M	78.59M	46.83M	72.83M	34.03M	2.93M	n/a
Cost of Revenue	n/a	189.08M	2.98M	2.4M	62.1M	825K	205K
Gross Profit	39.7M	-110.49M	43.85M	70.44M	-28.07M	2.11M	-205K
Operating Income	-261.63M	-165.53M	-161.26M	-100.53M	-46.3M	-42.2M	-21.45M
Interest Income	38.03M	18.76M	6.62M	488K	826K	1M	n/a
Pretax Income	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M	-41.25M	-21.47M
Net Income	-223.86M	-146.96M	-151.83M	-98M	-43.95M	-41.29M	-21.47M
Selling & General & Admin	63.53M	55.04M	43.83M	36.34M	18.23M	7.98M	3.77M
Research & Development	240.25M	189.08M	164.25M	137.02M	62.1M	37.16M	17.68M
Other Expenses	4.92M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	308.71M	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Interest Expense	249K	196K	176K	175K	115K	46K	16K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	308.71M	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Income Tax Expense	n/a	n/a	-2.98M	-2.22M	-1.65M	46K	43.86K
Shares Outstanding (Basic)	75.04M	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
Shares Outstanding (Diluted)	75.04M	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
EPS (Basic)	-2.98	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EPS (Diluted)	-2.98	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EBITDA	-216.24M	-143.2M	-151.66M	-97.64M	-43.72M	-40.38M	-21.25M
EBIT	-223.61M	-146.77M	-154.63M	-100.04M	-45.48M	-41.2M	-21.45M
Depreciation & Amortization	7.37M	3.56M	2.98M	2.4M	1.76M	825K	205K